ASTELLAS PHARMA, INC. (ALPMF)
Clinical trial NCT06862219: enrollment: not set → 100 participants.
Clinical trial NCT06862219: enrollment: not set → 100 participants.
Clinical trial NCT07388667 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: not set → 120 participants
Clinical trial NCT04145622: enrollment: not set → 250 participants.
Clinical trial NCT05979441: enrollment: not set → 240 participants.
Clinical trial NCT07561294: enrollment: not set → 350 participants.
Clinical trial NCT02403505 updates: 1. completion date: 2026-02-28 → 2026-12-28 2. primary completion date: 2026-02-28 → 2026-11-28 3. enrollment: not set → 20 participants
Clinical trial NCT04305054 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-20 → 2026-05-18 3. primary completion date: 2026-05-20 → 2026-05-18 4. enrollment: not set → 335 participants
Clinical trial NCT06824103 updates: 1. completion date: 2032-01-11 → 2031-05-23 2. enrollment: not set → 50 participants
Clinical trial NCT06333951 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2031-10-27 → 2026-11-30 3. primary completion date: 2028-10-27 → 2026-10-31 4. enrollment: not set → 49 participants
Clinical trial NCT07013474 updates: 1. completion date: 2027-05-06 → 2028-02-25 2. primary completion date: 2026-12-06 → 2027-09-27 3. enrollment: not set → 300 participants